0%

Posts Tagged ‘Survivor‘

HomeSurvivor

Starting Friday, November 3rd, the June E. Nylen Cancer Center along with the National Lung Cancer Alliance (LCA) will promote “Shine A Light For Lung Cancer Awareness”. This is a national campaign to educate the community on the importance of early detection and risk factors for lung cancer. There will be an educational display in […]

The Leukemia & Lymphoma Society (LLS) announced the U.S. Food and Drug Administration (FDA) approval of a new, personalized cell therapy that supercharges the patient’s immune system to find and kill cancer cells. This therapy, known as CAR (chimeric antigen receptor) T-cell immunotherapy, is approved to treat adults with several types of relapsed and refractory non-Hodgkin […]

Breast cancer is a group of diseases that affects breast tissue. Both women and men can get breast cancer, though it is much more common in women. Other than skin cancer, breast cancer is the most common cancer among women in the United States. Some women are at higher risk for breast cancer than others […]

September is Blood Cancer Awareness Month Blood cancers are cancers of the blood, bone marrow or lymph nodes that affect normal blood cell production or function. Today, nearly 1.3 million people in the United States are living with, or are in remission from, leukemia, lymphoma or myeloma.  Blood cancer can affect anyone, at any time. […]

 From the Leukemia & Lymphoma Society FDA Approval: LLS Applauds New Advance for Acute Lymphoblastic Leukemia RYE BROOK, N.Y. (August 17, 2017) – The Leukemia & Lymphoma Society (LLS) applauds today’s approval by the U.S. Food and Drug Administration (FDA) of inotuzumab ozogamicin (Besponsa®) for the treatment of adults with relapsed or refractory B-cell precursor […]

color
http://nylencancercenter.com/wp-content/themes/yunik-installable/
http://nylencancercenter.com/
#39489C
style3
paged
Loading posts...
#39489C
on
none
loading
#39489C
Sort Gallery
http://nylencancercenter.com/wp-content/themes/yunik-installable
on
yes
yes
off
on
off
off